Leo Pharma Sues Perrigo Israel Over Generic Taclonex

By Dan Rivoli · February 16, 2011, 5:18 PM EST

Leo Pharma A/S has sued generic-drug maker Perrigo Israel Pharmaceuticals Ltd. to block it from selling its own version of the Danish company's Taclonex ointment, used to treat the skin disease...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Leo Pharma A/S v. Perrigo Isrel Pharma Ltd.

Case Number

1:11-cv-00963

Court

New York Southern

Nature of Suit

Patent

Date Filed

February 14, 2011

Featured Stories

4 ERISA Cases To Watch In The 2nd Half Of 2025 No Photo Available

Kellie Mejdrich

The U.S. Department of Labor's challenge to a pair of injunctions blocking Biden-era regulations that broaden who qualifies as an inve... (more story)

Attorneys Say Look Before Leaping Back Into Senior Housing No Photo Available

Georgia Kromrei

Attorneys advising on senior housing deals are seeing more interest from investors and developers, due to demographic trends and the p... (more story)

High Court Concurrences Signal Hard Battle For Trans Rights No Photo Available

Katie Buehler

U.S. Supreme Court Justice Amy Coney Barrett joined the court's two most conservative members Wednesday to suggest laws that different... (more story)